• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login/ Register
    • About
  • Issue Archive
  • Advertise

Sponsored Content

Biofortis

EasyBioM® – Data Visualisation in a few clicks

February 16, 2022 Erwann Scaon

We are faced with the generation of very large volumes of complex NGS data, which presents a huge challenge for its analysis, and with the question how we can derive a simple scientific interpretation and […]

Pharma & Human Health

Microbiome in the Greater Copenhagen Region

March 8, 2021 Maria Anckarsvärd

As interest in microbiome is rapidly growing globally, the Greater Copenhagen region – spanning Eastern Denmark and the southernmost part of Sweden – offers international businesses and researchers a unique combination of a rich ecosystem […]

Finance

The Microbiome Industry Year in Review with Adrien Nivoliez: The LBP manufacturing perspective

December 22, 2020 Kristina Campbell

The regulatory environment for live biotherapeutic products is still uncertain globally, of course, but one booming area is the manufacturing of these products as they move through their clinical development process. Adrien Nivoliez, CEO of Biose Industrie reflects on […]

Pharma & Human Health

Leading immune-focused microbiome drug company taps Biose Industrie for manufacturing expertise

November 27, 2020 Microbiome Times

Every microbiome-focused company has its own approach for discovering drug candidates—but rarely is the mechanism of action for a live biotherapeutic product (LBP) known from the outset. Microbiome pharma company ImmunoBiome, however, uses a unique […]

Sponsored Content

A Checklist for Moving an LBP Through Manufacturing: The Biotech – CDMO Relationship

May 29, 2020 Kristina Campbell

With increasing evidence for microbial involvement in many human diseases, live biotherapeutic products (LBPs)—living microbes administered therapeutically—have emerged as a group of exciting new drug candidates. Although the LBP regulatory environment remains uncertain, companies all […]

Editor's Choice

The Human Microbiome: A Diversity of Players Ranging from Academics to Dedicated Platforms

April 3, 2019 Biofortis Mérieux NutriSciences and Cepton Strategies

Following Biofortis first paper The human microbiome: a global overview of clinical trials activity, this article compares the emergence of the human microbiome field with the rise of human genomics through a review on how […]

Pharma & Human Health

The Human Microbiome: A Global Overview of Clinical Trials Activity

February 5, 2019 Biofortis Mérieux NutriSciences and Cepton Strategies

While“healthy” microbiome remains to be defined, microbiome disruption is associated with numerous diseases, offering new therapeutic opportunities if causalities are demonstrated. Europe is at the forefront of the understanding of the Microbiome and is well placed […]

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • Fecal Microbiota Transplantation (FMT): Global Industry and Regulatory Overview
    June 27, 2022
  • Validation of the predictive role of A.muciniphila for response and resistance to PD1 blockade in non small cell lung cancers
    April 15, 2022
  • Did you miss Probiota Copenhagen 2022? Catch up now!
    April 12, 2022
  • A new strategy for editing DNA within microbial communities using CRISPR-Cas9 technology
    February 18, 2022
  • Protecting and Preserving the Intestinal Microbiome from Antibiotic-induced Dysbiosis with DAV132
    February 17, 2022
sign up

Sign up to the Microbiome Times newsletter